Following three clinical trials, the FDA has approved a new preventive treatment for neonates, infants, and toddlers that prevents respiratory syncytial virus (RSV) in those age populations.
Did you get the chance to view our Multidisciplinary Roundtable on some hot topics in treating patients with HIV? Here are some highlights that you may have missed.
This COVID-19 roundup includes a summary of studies on the effective treatment options for patients with long COVID, the risk of patients developing medical or mental health conditions post-hospitalization...
This COVID-19 roundup includes coverage of the combination of amubarvimab and romlusevimab to manage COVID-19 infection, the association between COVID-19 and incident diabetes, and the effectiveness of...
This COVID-19 roundup includes coverage of the FDA’s simpler vaccination schedule and authorization of new treatment, decline in pediatric asthma diagnoses during pandemic, and a new treatment combination...
Researchers aimed to determine the risk profile of individuals without HIV who were seeking vaccination against mpox and if these patients would benefit from HIV pre-exposure prophylaxis use.
Researchers determined the predictive value of urine point-of-care tenofovir antibody test and compared the results against self-reported PrEP use and TFV-diphosphate levels in dried blood spots. Their...
This COVID-19 roundup includes coverage of the FDA’s amendment to its emergency use authorization of the Pfizer-BioNTech booster for pediatric patients, acute myocardial infection deaths rose during omicron...
